• Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
  
• Mutation; HGNC; 7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; 9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
  

PubMed=7511045
Kokontis J.M., Takakura K., Hay N., Liao S.-T.
Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.
Cancer Res. 54:1566-1573(1994)

PubMed=9658399; DOI=10.1210/mend.12.7.0136
Kokontis J.M., Hay N., Liao S.-T.
Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
Mol. Endocrinol. 12:941-953(1998)

PubMed=16015608; DOI=10.1002/pros.20285
Kokontis J.M., Hsu S., Chuu C.-P., Dang M., Fukuchi J., Hiipakka R.A., Liao S.-T.
Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
Prostate 65:287-298(2005)